MX9100441A - Procedimiento para fabricar preparados solidos orales,que contienen ifosfamida como agente activo - Google Patents
Procedimiento para fabricar preparados solidos orales,que contienen ifosfamida como agente activoInfo
- Publication number
- MX9100441A MX9100441A MX9100441A MX9100441A MX9100441A MX 9100441 A MX9100441 A MX 9100441A MX 9100441 A MX9100441 A MX 9100441A MX 9100441 A MX9100441 A MX 9100441A MX 9100441 A MX9100441 A MX 9100441A
- Authority
- MX
- Mexico
- Prior art keywords
- ifosfamide
- procedure
- contain
- active agent
- oral solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4024683 | 1990-08-03 | ||
SG181694A SG181694G (en) | 1990-08-03 | 1994-12-30 | Solid oral administration forms containing ifosfamide as active agent |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9100441A true MX9100441A (es) | 1992-04-01 |
Family
ID=25895607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9100441A MX9100441A (es) | 1990-08-03 | 1991-07-30 | Procedimiento para fabricar preparados solidos orales,que contienen ifosfamida como agente activo |
Country Status (33)
Country | Link |
---|---|
US (1) | US5158776A (es) |
EP (1) | EP0469440B1 (es) |
JP (2) | JP3061898B2 (es) |
KR (1) | KR0177170B1 (es) |
CN (1) | CN1046851C (es) |
AR (1) | AR247484A1 (es) |
AT (1) | ATE110261T1 (es) |
AU (2) | AU643309B2 (es) |
BG (1) | BG60900B1 (es) |
CA (1) | CA2048367C (es) |
CZ (1) | CZ280475B6 (es) |
DE (2) | DE4124481A1 (es) |
DK (1) | DK0469440T3 (es) |
EG (1) | EG19690A (es) |
ES (1) | ES2058999T3 (es) |
FI (1) | FI97951C (es) |
HK (1) | HK15695A (es) |
HR (1) | HRP920575B1 (es) |
HU (1) | HU206268B (es) |
IE (1) | IE66378B1 (es) |
IL (1) | IL99031A (es) |
LT (1) | LT3528B (es) |
LV (1) | LV10043B (es) |
MC (1) | MC2274A1 (es) |
MX (1) | MX9100441A (es) |
NO (1) | NO178252C (es) |
NZ (1) | NZ239222A (es) |
PT (1) | PT98532B (es) |
RO (1) | RO113611B1 (es) |
SG (1) | SG181694G (es) |
SI (1) | SI9111342B (es) |
SK (2) | SK279740B6 (es) |
ZA (1) | ZA916124B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0804174A4 (en) * | 1993-07-21 | 1998-09-09 | Univ Kentucky Res Found | MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS |
ITFI970184A1 (it) * | 1997-07-30 | 1999-01-30 | Menarini Farma Ind | Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico |
DE19733305A1 (de) * | 1997-08-01 | 1999-02-04 | Asta Medica Ag | Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin |
US6103297A (en) * | 1998-01-14 | 2000-08-15 | Matsushita Electronics Corporation | Method of manufacturing cathode-ray tube |
DE19826517B4 (de) * | 1998-06-15 | 2006-03-23 | Baxter Healthcare S.A. | Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette |
US20040253307A1 (en) * | 2003-02-04 | 2004-12-16 | Brian Hague | Sugar-free oral transmucosal solid dosage forms and uses thereof |
DE102005008797A1 (de) * | 2005-02-25 | 2006-09-07 | Baxter International Inc., Deerfield | Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung |
EP3091974B1 (en) * | 2014-01-06 | 2020-04-01 | Shield TX (UK) Limited | Dosage regimen of ferric trimaltol |
GB201418710D0 (en) | 2014-10-21 | 2014-12-03 | Iron Therapeutics Holdings Ag | Dosage regimen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5646807A (en) * | 1979-09-27 | 1981-04-28 | Japan Atom Energy Res Inst | Production of composition of complex gradually releasing physiologically active substance |
DE3111428A1 (de) * | 1981-03-24 | 1982-10-07 | Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld | Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
US4618692A (en) * | 1981-09-03 | 1986-10-21 | Asta-Werke Aktiengesellschaft | 4-carbamoyloxy-oxazaphosphorins |
US5019385A (en) * | 1984-11-09 | 1991-05-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Novel lymphopine LK 2 and pharmaceutic compositions containing same |
DE3722043A1 (de) * | 1986-07-11 | 1988-01-14 | Asta Werke Ag Chem Fab | Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung |
DE3804686A1 (de) * | 1988-02-15 | 1989-08-24 | Henkel Kgaa | Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten |
-
1991
- 1991-07-15 RO RO148008A patent/RO113611B1/ro unknown
- 1991-07-24 DE DE4124481A patent/DE4124481A1/de not_active Withdrawn
- 1991-07-24 ES ES91112368T patent/ES2058999T3/es not_active Expired - Lifetime
- 1991-07-24 MC MC912206A patent/MC2274A1/xx unknown
- 1991-07-24 DK DK91112368.5T patent/DK0469440T3/da active
- 1991-07-24 US US07/733,756 patent/US5158776A/en not_active Expired - Lifetime
- 1991-07-24 EP EP91112368A patent/EP0469440B1/de not_active Expired - Lifetime
- 1991-07-24 AT AT91112368T patent/ATE110261T1/de not_active IP Right Cessation
- 1991-07-24 DE DE59102620T patent/DE59102620D1/de not_active Expired - Fee Related
- 1991-07-30 MX MX9100441A patent/MX9100441A/es unknown
- 1991-07-31 JP JP3191414A patent/JP3061898B2/ja not_active Expired - Fee Related
- 1991-08-01 IL IL9903191A patent/IL99031A/en not_active IP Right Cessation
- 1991-08-01 SI SI9111342A patent/SI9111342B/sl not_active IP Right Cessation
- 1991-08-01 PT PT98532A patent/PT98532B/pt not_active IP Right Cessation
- 1991-08-01 NZ NZ239222A patent/NZ239222A/xx not_active IP Right Cessation
- 1991-08-01 BG BG94934A patent/BG60900B1/bg unknown
- 1991-08-01 EG EG46991A patent/EG19690A/xx active
- 1991-08-02 CA CA002048367A patent/CA2048367C/en not_active Expired - Lifetime
- 1991-08-02 NO NO913019A patent/NO178252C/no not_active IP Right Cessation
- 1991-08-02 AR AR91320329A patent/AR247484A1/es active
- 1991-08-02 CZ CS912409A patent/CZ280475B6/cs not_active IP Right Cessation
- 1991-08-02 CN CN91105271A patent/CN1046851C/zh not_active Expired - Fee Related
- 1991-08-02 AU AU81589/91A patent/AU643309B2/en not_active Ceased
- 1991-08-02 IE IE277491A patent/IE66378B1/en not_active IP Right Cessation
- 1991-08-02 HU HU912594A patent/HU206268B/hu not_active IP Right Cessation
- 1991-08-02 SK SK2409-91A patent/SK279740B6/sk not_active IP Right Cessation
- 1991-08-02 ZA ZA916124A patent/ZA916124B/xx unknown
- 1991-08-02 FI FI913710A patent/FI97951C/fi active
- 1991-08-02 KR KR1019910013365A patent/KR0177170B1/ko not_active IP Right Cessation
-
1992
- 1992-09-29 HR HRP-1342/91A patent/HRP920575B1/xx not_active IP Right Cessation
- 1992-10-27 LV LVP-92-172A patent/LV10043B/lv unknown
-
1993
- 1993-08-23 AU AU44836/93A patent/AU649184B2/en not_active Ceased
- 1993-09-03 LT LTIP921A patent/LT3528B/lt not_active IP Right Cessation
-
1994
- 1994-12-30 SG SG181694A patent/SG181694G/en unknown
-
1995
- 1995-02-06 HK HK15695A patent/HK15695A/xx not_active IP Right Cessation
-
1998
- 1998-04-27 SK SK543-98A patent/SK279739B6/sk not_active IP Right Cessation
-
2000
- 2000-01-14 JP JP2000006836A patent/JP3545300B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES513183A0 (es) | "un procedimiento para preparar una composicion herbicida que contiene como ingrediente activo una 3-isoxazolidinona". | |
NL185390C (nl) | Element, bestemd voor implantatie in beenderweefsel. | |
ES2159591T3 (es) | Composicion de liberacion controlada. | |
ES531978A0 (es) | Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona. | |
ES555450A0 (es) | Un metodo para preparar una composicion de accion prolongada, que contiene un agente biologicamente activo | |
MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
AR240250A1 (es) | Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo. | |
ES494614A0 (es) | Procedimiento para la obtencion de 1,4-dihidropiridinas op- ticamente activas | |
PT91246A (pt) | Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo | |
ES508670A0 (es) | Procedimiento de preparacion de derivados aminoalcoil heterociclicos farmaceuticamente activos. | |
AR240225A1 (es) | Composicion insecticida que comprende mas de un compuesto activo. | |
ES482131A0 (es) | Procedimiento para esterilizar un agente de contraste de ra-yos x de m-carboxamido-o-yodo-n-(b-hidroxialcohil)-anilina. | |
ES2163461T3 (es) | Procedimiento para la obtencion de comprimidos efervescentes. | |
FI970530A0 (fi) | Koostumus aktiivisen aineen selektiiviseksi vapauttamiseksi | |
MX9100441A (es) | Procedimiento para fabricar preparados solidos orales,que contienen ifosfamida como agente activo | |
DE3267295D1 (en) | Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle | |
ES525574A0 (es) | Procedimiento para producir preparaciones farmaceuticas que contienen como substancias activas derivados de polialquilenglicol. | |
ES503878A0 (es) | Un procedimiento para la preparacion de un derivado cis-4,5-disustituidos de imidazolidin-2-ona opticamente activo. | |
MX24039A (es) | Composiciones farmaceuticas que contienen una calcitonina como principio activo. | |
IT1094915B (it) | Perborato di sodio solido superossidato,e procedimento per fabbricarlo | |
BR8802557A (pt) | Agente fisiologicamente ativo para uso agricola | |
TR200200683T2 (tr) | Oral kontrollü salıverme formülasyonları. | |
AR229598A1 (es) | Esteres 5-amino-1-fenilpirazol-4-carboxilicos,un procedimiento para la obtencion de los mismos y composiciones herbicidas que los contienen como agente activo | |
AR220113A1 (es) | Composiciones fungicidas que contienen n-benzoilantranilatos como agente activo,procedimiento para prepararlas y nuevos n-benzoilantranilatos de aplicacion en dichas composiciones | |
ES509417A0 (es) | Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas |